NIYATILEAS

Veerhealth Care Share Price

 

 

Start SIP in NIYATILEAS

Start SIP

Performance

  • Low
  • ₹18
  • High
  • ₹19
  • 52 Week Low
  • ₹9
  • 52 Week High
  • ₹24
  • Open Price₹19
  • Previous Close₹19
  • Volume78,181
  • 50 DMA₹18.59
  • 100 DMA₹18.56
  • 200 DMA₹18.48

Investment Returns

  • Over 1 Month -3.09%
  • Over 3 Month -4.87%
  • Over 6 Month -14.03%
  • Over 1 Year -8.05%

Smart Investing Starts Here Start SIP with Veerhealth Care for Steady Growth!

Invest Now

Veerhealth Care Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 75.8
  • PEG Ratio
  • 0.1
  • Market Cap Cr
  • 35
  • P/B Ratio
  • 1.5
  • Average True Range
  • 1
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • 0.09
  • RSI
  • 38.2
  • MFI
  • 62.25

Veerhealth Care Financials

Veerhealth Care Technicals

EMA & SMA

Current Price
₹17.59
-0.91 (-4.92%)
  • Bearish Moving Average 0
  • Bullish Moving Average 0
  • 20 Day
  • ₹18.64
  • 50 Day
  • ₹18.59
  • 100 Day
  • ₹18.56
  • 200 Day
  • ₹18.48

Resistance and Support

18.11 Pivot Speed
  • R3 20.36
  • R2 19.75
  • R1 18.72
  • S1 17.08
  • S2 16.47
  • S3 15.44

Veerhealth Care Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-12 Quarterly Results
2025-08-12 Quarterly Results & A.G.M.
2025-05-30 Audited Results & Final Dividend
2025-02-12 Quarterly Results
2024-11-14 Quarterly Results
Date Purpose Remarks
2023-09-22 Bonus Rs.0.00 issue in the ratio of 1:1 of Rs. 10/-.

Veerhealth Care F&O

Veerhealth Care Shareholding Pattern

No data available.

Veerhealth Care FAQs

Veerhealth Care share price is ₹17 As on 14 January, 2026 | 08:26

The Market Cap of Veerhealth Care is ₹35.2 Cr As on 14 January, 2026 | 08:26

The P/E ratio of Veerhealth Care is 75.8 As on 14 January, 2026 | 08:26

The PB ratio of Veerhealth Care is 1.5 As on 14 January, 2026 | 08:26

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23